Learn More
Invitrogen™ SARS Coronavirus Spike Protein Polyclonal Antibody

Description
The immunogen is 87% (13/15) homologous to SARS-COV-2 (COVID-19) Spike protein. The cross reactivity is not empirically tested. Suggested positive control: transfected mouse melanoma cell lysate. Immunogen sequence: QYGSFCTQLN RALTG.
Specifications
Specifications
| Antigen | SARS Coronavirus Spike Protein |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.2% gelatin and 0.05% sodium azide |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Host Species | Rabbit |
| Immunogen | Synthetic peptide corresponding to amino acids 755-769 from the S (Spike glycoprotein) (Spike protein 2) for the Human SARS coronavirus. |
| Purification Method | Protein G |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.